NHMRC Centre of Research Excellence in Mental Health and Substance Use (CREMS), National Drug and Alcohol Research Centre, UNSW 2

Similar documents
LONG-TERM TREATMENT OUTCOME: WHAT ARE THE 11 YEAR OUTCOMES OF TREATMENT FOR HEROIN DEPENDENCE?

The treatment of heroin dependence presents

NDARC Technical Report No.139. J. Ross, M. Teesson, S. Darke, M. Lynskey, K. Hetherington, K. Mills, A. Williamson & S. Fairbairn.

HIGH SUCCESS RATE OF BUTTERY REHABILITATION PROGRAMS

Young people with heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)

Abstinence and drug abuse treatment: Results from the Drug Outcome Research in Scotland study

WHOS have 13 years experience working with OST clients. MTAR (Methadone to Abstinence Residential) reduction program in 1999

Ass Professor Frances Kay-Lambkin. NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW

Treatment of Co-existing Depression and Substance Use

Mothers on the Opioid Treatment Program and their involvement with the child protection system. Stephanie Taplin and Richard Mattick

How To Understand The Atop

The story of drug treatment

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

Powder speed, whiz, velocity - Usually snorted, ingested or injected

What are the outcomes for assessing drug treatment? A review of long-term observational studies on the treatment of opioid dependence

A quick glance around the recent research articles and resources that we have found interesting.

The Integration of Harm Reduction into Abstinence-based Therapeutic Communities: A Case Study of We Help Ourselves

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

Treatment Approaches for Drug Addiction

THE STORY OF DRUG TREATMENT

The leading voice in Indigenous drug and alcohol policy advice. AIJA INDIGENOUS JUSTICE CONFERENCE Thursday 18 July Friday 19 July, 2013

Getting help for a drug problem A guide to treatment

Overview of the Breaking Free research and evaluation programme. Based on the MRC framework for developing and evaluating complex interventions

POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM

Current Issues Psychostimulant use

Treatment Approaches for Drug Addiction

EPIDEMIOLOGY OF OPIATE USE

WHAT YOU NEED TO KNOW

Alexandre B. Laudet, PhD. Correspondence:

A 10-year follow-up study of drug users in treatment. Grethe Lauritzen, SIRUS

People with mental health disorders and cognitive impairment in the criminal justice system Cost-benefit analysis of early support and diversion*

How To Write The Merit Residential Treatment Guidelines

Opioid Agonist Treatment in Correctional Settings

Treatment of opioid use disorders

Queensland Corrective Services Drug and Alcohol Policy

Specialist Alcohol & Drug Services in Lanarkshire

Overview of the Adverse Childhood Experiences (ACE) Study. Robert F. Anda, MD, MS Co-Principal Investigator.

drug treatment in england: the road to recovery

Meeting Current and Future Demand for Drug Treatment in North Canberra: Expanding Opioid Maintenance Treatment and Needle and Syringe Programs

YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT

Working with young people who have mental health and substance use issues. Samar Zakaria

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

INTRODUCTION. a. Value of merchandise stolen. b. Costs of medical care for crime victims. c. Productivity losses. d. Cost for police protection.

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

Predictors of Substance Abuse Treatment Engagement among Rural Appalachian Prescription Drug Users

Aim of presentation. Drug and Alcohol Services in Leicester. National Policy. Local Policy. Demographics. Aims and objectives of needs assessment

The Adverse Health Effects of Cannabis

Treatment System 101

Key trends nationally and locally in relation to alcohol consumption and alcohol-related harm

Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?

Development of the guidelines on the pharmacotherapy of addiction case study Croatia

THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32

MORTALITY AMONGST ILLICIT DRUG USERS

African American Women and Substance Abuse: Current Findings

Discontinuation: Involuntary Discharge

Phoenix Futures Prison Treatment programmes

People affected by drug and alcohol misuse

Do you, or anyone you know, want to be free from drugs or alcohol misuse? We're here to help

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

DrugFacts: Treatment Approaches for Drug Addiction

Characteristics and Outcomes Site Profiles Report Guide

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Stuck in a Moment in Time: PTSD and Substance Use Disorders

Treatment of Prescription Opioid Dependence

Adults who misuse drugs and alcohol

MERIT residential treatment guidelines. a guide for MERIT teams and residential treatment providers

To detox or not to detox: whose choice is it anyway? Dr Ed Day Senior Lecturer in Addiction Psychiatry University of Birmingham

Fairfax-Falls Church Community Services Board

Oxfordshire Drug and Alcohol Treatment System

Directory for Substance Misuse Services in Caerphilly

Program Prevention of HCV infections

R. McKetin, E. Kelly, D. Indig & J. McLaren. Characteristics of Treatment Provided For Amphetamine Use in NSW, NDARC Technical Report No.

Michael Brennan, MA, LMHC Providence St. Peter Hospital Crisis Services

Your Company 123 Company Ave. Philadelphia PA (215) COMPARISON REPORT. John B Smith

Restoring Hope...Rebuilding Lives

Treatment Approaches for Drug Addiction

Anti-Social Personality Disorder

NADA submission to: NSW Parliament Legislative Council Inquiry into Drug and Alcohol Treatment

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009

Recovery Outcomes for Opiate Users. FRN Research Report November 2013

A LONG-TERM STUDY OF THE OUTCOMES OF DRUG USERS LEAVING TREATMENT SEPTEMBER 2010

Developing the Guernsey treatment system for substance misusers: Phases One and Two. Helen Baldwin Linda Prickett Adam Marr Jim McVeigh

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

Joint Committee on Health and Children

Directions for your Mental Health

Cannabis and residential treatment

Care Management Council submission date: August Contact Information

DMRI Drug Misuse Research Initiative

THE DEDHAM COALITION FOR ALCOHOL AND DRUG AWARENESS

Opioid overdose can occur when a patient misunderstands the directions

FACTSHEET: DUAL DIAGNOSIS

Alcohol and other drug treatment services in Australia

Table of Contents. I. Introduction II. Summary A. Total Drug Intoxication Deaths B. Opioid-Related Deaths... 9

There is a growing epidemiological and clinical literature

methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

Amphetamine-Type Stimulant (ATS) Use

Topic Area - Dual Diagnosis

Transcription:

Maree Teesson 1, Christina Marel 1, Katherine Mills 1, Shane Darke 2, Joanne Ross 1, Tim Slade 1, Jo White 1, Sonja Memedovic 1, Michael Lynskey 2 and Lucinda Burns 3 1 NHMRC Centre of Research Excellence in Mental Health and Substance Use (CREMS), National Drug and Alcohol Research Centre, UNSW 2 National Addiction Centre, Kings College, London 3 National Drug and Alcohol Research Centre, UNSW

Funders and Collaborators All participants who give their time and experiences. AOD treatment agencies National Health and Medical Research Council (NHMRC) Australian Department of Health National Drug and Alcohol Research Centre NSW Ministry of Health NSW Pharmacy Guild NSW Users and AIDS Association Hepatitis NSW Australia and NSW Needle and Syringe Programs Interstate collaborators: Prof. Alison Ritter, Prof. Robert Ali. ATOS Researchers Sarah Ellis Philippa Ewer Sandra Fairbairn Dr Alys Havard Nicky Henderson Kate Hetherington Dr Christina Marel Sonja Memedovic Dr Louise Mewton A/Prof Katherine Mills Joanne White Evelyn Wilhelm Dr Anna Williamson

Shane Darke Jo Ross Maree Teesson Alys Havard Kath Mills Kate Hetherington & Anna Williamson

A prospective, longitudinal cohort study One of the few studies focusing on heroin dependence N=615 8 not in treatment 535 entering treatment 21 entering MT 21 entering detox 135 entering resi rehab

In 211-12, more people sought treatment for heroin use in Australia than any other illicit drug (n=65,952) (AIHW 212). Heroin dependence How persistent? How chronic? Relapsing condition? When?

Baseline (N=615) % Male 66.2 Mean age 29 % Heroin dependent 97.6 Mean length of heroin use career (years) 9.6 Mean number of drug classes used 4.9 % In current treatment for opiate dependence 87. % Major depression 24.6 % Current PTSD 29.4

Percent 1 8 6 4 2 1.3.8 (n=615) 89 (n=549) 81 (n=495) 1.5 76 (n=469) 2.1 7 (n=429) 6 5 4 3 2 1 Number Baseline 3-mths 1-yr 2-yr 3-yr 11-yr Wave % Interviewed % Deceased N Interviewed

Percent 1 8 6 4 2 1.3.8 (n=615) 89 (n=549) 81 (n=495) 1.5 76 (n=469) 2.1 7 (n=429) N=63 (1.2) 7 (n=431) 6 5 4 3 2 1 Number Baseline 3-mths 1-yr 2-yr 3-yr 11-yr Wave % Interviewed % Deceased N Interviewed

Jo White & Sonja Memedovic & Philipa Ewer Chris Marel

Baseline interviews 21-22 11-year interviews 211-213

We don t know what happens over the longterm for people with heroin dependence Are there indicators that can tell us what is likely to happen over the long-term for their heroin use?

Baseline (N=615) 11-years (N=431) % Male 66.2 64.5 Mean age 29 4 % Crime main source of income 23.9 2.1 % Used heroin in past month 98.7 24.8 % Heroin dependent 97.6 15.1 Mean number of drug classes used 4.9 3.2 % In current treatment for opiate dependence 87. 46.6 % Major depression 24.6 2.9

Percentage 1 8 6 4 2 99 96 25 85 68 42 53 56 48 32 4 4 3 29 18 27 9 2 27 Baseline 11-years

Two stage process: Modelled trajectories of heroin use, and calculated the probability of belonging to a specific group Entering variables into the model to predict those pathways *Finite mixture modelling: specifically group based mixture modelling approach (Jones, et al 21; Nagin 25)

We found 6 pathways of heroin use over 11- years

Trajectory % 1. Early decrease to maintained abstinence 16.2 2. Early decrease with early relapse 7.1 3. Early decrease with late relapse 14.4 4. Gradual decrease to near abstinence 19.1 5. Gradual decrease 21.5 6. No decrease 21.7

1.8 16.2% Probability.6.4.2 1 12 2 3 3 4 4 5 5 6 6 7 78 8 9 1 9 1 11 Early decrease to maintained abstinence (mean) Year Early decrease to maintained abstinence (predicted)

1.8 7.1% Probability.6.4.2 1 12 23 34 45 56 67 78 89 1 9 111 Early decrease with early relapse (mean) Early decrease with early relapse (predicted) Year

1.8 14.4% Probability.6.4.2 1 12 23 34 45 56 67 78 89 1 9 111 Early decrease with late relapse (mean) Year Early decrease with late relapse (predicted)

1.8 19.1% Probability.6.4.2 1 12 23 34 45 56 67 78 89 1 9 111 Year Gradual decrease to near abstinence (mean) Gradual decrease to near abstinence (predicted)

1 Probability.8.6.4.2 21.5% 1 12 23 34 45 56 67 78 89 1 9 111 Year Gradual decrease (mean) Gradual decrease (predicted)

1 Probability.8.6.4.2 21.7% 1 12 23 34 45 56 67 78 89 1 9 111 Year No decrease (mean) No decrease (predicted)

1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Early decrease to maintained abstinence (mean) Early decrease with early relapse (mean) Early decrease with late relapse (mean) Gradual decrease to near abstinence (mean) Gradual decrease (mean) No decrease (mean) Year

1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Early decrease to maintained abstinence (mean) Early decrease with early relapse (mean) Early decrease with late relapse (mean) Gradual decrease to near abstinence (mean) Gradual decrease (mean) No decrease (mean) Year

Aim: to examine factors associated with each trajectory A series of multinomial logistic regressions were conducted on covariates hypothesised to be associated with heroin use trajectories

Demographic characteristics Sex, education Main source of income Homelessness Prison history Past month criminal involvement at baseline Physical and mental health General and physical and mental health ASPD BPD Current and lifetime PTSD Major depression Ever attempted suicide No. traumas Drug use history No. drug classes used last month Types of drugs used last month History of IDU Treatment history In current treatment Current treatment category Index treatment category No. previous rx episodes

Aged more than 3 Been using heroin for less than 1 years Ever overdosed Severe mental health disability Had experienced rape

Significantly more likely to be in the early decrease to maintained abstinence group. 1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Year

Significantly more likely to be in the early decrease with early relapse group. 1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Year

Significantly more likely to be in the gradual decrease to near abstinence group. 1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Year

Significantly more likely to be in the early decrease with early relapse group. 1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Year

Significantly more likely to be in the early decrease with early relapse group, early decrease with late relapse group, or gradual decrease to near abstinence group. 1.8 Probability.6.4.2 1 2 3 4 5 6 7 8 9 1 11 1 2 3 4 5 6 7 8 9 1 Year

1 Probability.8.6.4.2 21.7% 1 12 23 34 45 56 67 78 89 1 9 111 Year No decrease (mean) No decrease (predicted)

Heroin dependence is often a chronic, recurring condition, associated with complex trajectories. More than 8% of the cohort achieved some level of reduction in their heroin use. It is difficult to predict who will follow a chronic pathway The critical factors guiding trajectories are: Aged more than 3 Used heroin for less than 1 years History of overdose Ever been raped Severe mental health disability

Examining how treatment across the 11-year follow-up impacts upon a person s trajectory Continued follow-up of the ATOS cohort to examine the pathways of the group as they continue to age 1.8.6.4.2 1 2 3 4 5 6 7 8 9 1 11 12 13 14 15 1 2 3 4 5 6 7 8 9 1 11 12 13 14??????

m.teesson@unsw.edu.au Mental Health and Substance Use Thank you!